PUBLIC COMPANY
saveOhio State University Comprehensive Cancer Center
updated 3mo ago
community read0 votes
🐶 often sniffed alongside
top 4pipeline
0
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
- phase2Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
- phase2Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL
- phase1Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
- N/AEMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer
- phase2Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab
- phase1Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- —Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that